| Turquia | Áustria | Espanha | |
| Traquelectomia uterina | ≈ $2,800 | ≈ $5,200 | ≈ $10,000 |
| Terapia por protões para cancro da próstata | ≈ $30,000 | ≈ $28,000 | ≈ $22,000 |
| Terapia de radiação para o cancro colorretal | de $5,000 | de $6,700 | de $7,500 |
| Terapia de protões para cancro da mama | ≈ $28,000 | ≈ $24,000 | ≈ $16,000 |
| Terapia de protão | de $25,000 | ≈ $24,000 | ≈ $24,000 |
Como chefe do maior departamento de oncologia da Áustria e líder em imunoterapia, o Prof. Zielinski realizou mais de 1.100 tratamentos contra o cancro. Atualmente, lidera o Centro Internacional de Oncologia na Wiener Privatklinik.
O Prof. Univ. Dr. Wolfgang Köstler é especializado em cânceres de mama e ginecológicos, com mais de duas décadas de experiência em terapias direcionadas e medicina personalizada.
O Prof. Schoppmann é um pioneiro na cirurgia oncológica minimamente invasiva, especializado em cancros do esófago e do estômago na Wiener Privatklinik.
Assoc. Prof. Priv.-Doz. Dr. Alexander W. Hauswirth is a specialist in internal medicine and haemato‑oncology at JUVENIS. Since 2010, he has served as the lead senior physician for Haematology/Haemostaseology and Oncology at the Clinic for Internal Medicine I, Medical University of Vienna/AKH Vienna, Austria’s largest hospital.
He earned his medical degree from the University of Vienna in 1999. He received the venia docendi in 2010 and was appointed Associate Professor in 2012. He completed an additional haemato‑oncology qualification in 2014. As a Schrödinger Fellow in Salamanca in 2009–2010, he researched CLL stem and precursor cells. He has published regularly since 2000.
Accreditations include Austrian Medical Chamber diplomas in emergency medicine (since 2009) and sports medicine (2018). Awards include the Schrödinger Fellowship (2009), the ÖGHO award (2009), and the European Society of Chemotherapy poster award (2003). Clinical focus: anaemias, leukaemias, lymph node disorders, clotting and anticoagulation, and pre‑operative clearance. Languages: German and English.